Tharimmune
🇺🇸United States
TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis
Phase 2
Not yet recruiting
- Conditions
- PruritusPrimary Biliary Cholangitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-12-13
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- Tharimmune Inc
- Target Recruit Count
- 40
- Registration Number
- NCT06733519
An Evaluation of The Absolute Bioavailability of TH104
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Tharimmune Inc
- Target Recruit Count
- 20
- Registration Number
- NCT06198686
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Las Vegas, Nevada, United States
© Copyright 2025. All Rights Reserved by MedPath